Company Overview and News
San Mateo-based spend management firm Coupa (NASDAQ:COUP) went public more than two years ago. Its IPO has performed well as it continues to surpass market expectations and receive accolades for its products. Coupa values its addressable market at $37 billion and is targeting a share of $1 billion soon.
SAP AMZN ODP ORCL COUP
Investors with an interest in Retail - Miscellaneous stocks have likely encountered both Office Depot (ODP - Free Report) and Tractor Supply (TSCO - Free Report) . But which of these two stocks presents investors with the better value opportunity right now? Let's take a closer look.
Office Depot, Inc.’s (ODP - Free Report) focus on business operating model, growth prospects and omni-channel capabilities have aided the stock to gain and outpace the industry in the past three months. Shares of this Boca Raton, FL-based company have surged 33.5% compared with the industry that advanced 11.5%. Strategic endeavors, including strengthening of core businesses and expansion of service and subscription offerings fueled the top line that beat the consensus mark for the third time in a row and grew year over year during first-quarter 2018.
BGFV ODP FIVE
Investors in Office Depot, Inc. (ODP - Free Report) need to pay close attention to the stock based on moves in the options market lately. That is because the Jul 20, 2018 $5 Call had some of the highest implied volatility of all equity options today.
EPC ODP ZAGG
Value investing is easily one of the most popular ways to find great stocks in any market environment. After all, who wouldn’t want to find stocks that are either flying under the radar and are compelling buys, or offer up tantalizing discounts when compared to fair value? One way to find these companies is by looking at several key metrics and financial ratios, many of which are crucial in the value stock selection process.
Allied Motion Technologies, Inc. (AMOT - Free Report) is looking like an interesting pick from a technical perspective, as the company is seeing favorable trends on the moving average crossover front. Recently, the 50 Day Moving Average for AMOT broke out above the 200 Day Simple Moving Average, suggesting a short-term bullish trend.
AMOT ODP PSTI PSTIW ATVI
American Equity Investment Life Holding Company (AEL - Free Report) is looking like an interesting pick from a technical perspective, as the company is seeing favorable trends on the moving average crossover front. Recently, the 50 Day Moving Average for AEL broke out above the 200 Day Simple Moving Average, suggesting a short-term bullish trend.
ODP PSTI PSTIW ATVI
Archrock, Inc. (AROC - Free Report) is looking like an interesting pick from a technical perspective, as the company is seeing favorable trends on the moving average crossover front. Recently, the 50 Day Moving Average for AROC broke out above the 200 Day Simple Moving Average, suggesting a short-term bullish trend.
ODP PSTI AROC PSTIW ATVI
Fortress Biotech, Inc. (FBIO - Free Report) could be a stock to avoid from a technical perspective, as the firm is seeing unfavorable trends on the moving average crossover front. Recently, the 50 Day Moving Average for FBIO broke out below the 200 Day Simple Moving Average, suggesting short-term bearishness.
ODP PSTI FBIO PSTIW ATVI
Office Depot Inc (NYSE:ODP) keeps on fighting. Two years ago, the Federal Trade Commission appeared to deal the company a knockout blow. The country’s largest office supply chains, Staples and Office Depot, had intended to merge. For whatever bizarre reason, the FTC blocked the deal as being uncompetitive. ODP stock plunged following the decision.
AMZN ODP BBY
2018-07-17 - Asif
History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...
2018-07-17 - Asif
Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...
2018-07-16 - Asif
General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...
Silicon Investor Message Boards
This table lists all message boards related to ODP / Office Depot, Inc. on message board site Silicon Investor.
|Office Product Stocks - ODP/SPLS/OMX/VKNG/CEXP/OFIS/BOP||25% gain in days-PSDI,IDXX,MCSY,ODP,RATL,WGTI|
|OFFICE DEPOT, odp ,nyse|
as of ET